Judge Rules Against MedImpact In $200M Rite Aid Debt Dispute
Judge Rules Against MedImpact In $200M Rite Aid Debt Dispute
MedImpact's attempt to recoup approximately $200 million following its purchase of Rite Aid Corp's (OTC:RADCQ) pharmacy benefits unit has failed.
MedImpact试图在收购Rite Aid Corp（OTC：RADCQ）的药房福利部门后追回约2亿美元的款项，但未能成功。
U.S. Bankruptcy Judge Michael Kaplan ruled that MedImpact assumed Elixir's debts when it acquired the company.
美国破产法法官迈克尔·卡普兰判决，MedImpact在收购Elixir公司时承担了该公司的债务。
In a hearing, Judge Kaplan highlighted that MedImpact was aware of Elixir's negative cash balance, which stood at around $200 million.
法官卡普兰在听证会上指出，MedImpact公司知道Elixir公司的负现金余额约为2亿美元。
This deficit was mainly due to reimbursement payments owed to pharmacies, including CVS Health Inc (NYSE:CVS) and Walgreens Boots Alliance Inc (NASDAQ:WBA).
这个负债主要是由拖欠给药店的偿付款项而引起的，其中包括西维斯健康公司（纽交所：CVS）和沃尔格林-联合博姿公司（纳斯达克：WBA）。
Previously, Kaplan had approved MedImpact's $575 million acquisition of Elixir, confirming that the sale agreement included the transfer of Elixir's debts to MedImpact.
此前，卡普兰法官已批准了MedImpact以5.75亿美元的价格收购Elixir公司，并确认该销售协议包括将Elixir公司的债务转让给MedImpact公司。
This decision is crucial as it underscores the financial obligations that MedImpact inherited with the purchase.
此次判决具有重要意义，它突显了MedImpact公司在收购中承担的财务义务。
Rite Aid, a major U.S. pharmacy retailer, filed for bankruptcy in October, citing substantial debt, declining revenue, increased competition, and litigation over its involvement in the U.S. opioid crisis as primary factors.
美国主要药房零售商Rite Aid在去年10月申请破产，称其主要因素包括巨额债务、营业收入下降、竞争加剧以及涉及美国阿片类药物危机的诉讼。
The dispute with MedImpact, a pharmacy benefit manager, posed a significant threat to Rite Aid's overall restructuring plan, which awaits final court approval on Thursday, Reuters highlighted.
据路透社指出，与药店福利管理公司MedImpact的争议对Rite Aid的整体重组计划构成了重大威胁，该计划将在周四获得最终法院批准。
Judge Kaplan remarked that Rite Aid was in no position to cover Elixir's old debts, given its financial struggles and efforts to raise cash while reducing liabilities.
卡普兰法官表示，鉴于Rite Aid的财务困难和筹集资金以减少负债的努力，该公司无力偿还Elixir的旧债务。
"It is no secret that money in this case is tight, and there is little wiggle room, let alone over $200 million of wiggle room," Kaplan stated.
卡普兰表示：“这个案子里钱紧张，根本没有超过2亿美元的余地。”
Rite Aid's bankruptcy plan aims to reduce its debt by $2 billion and allocate $47.5 million to junior creditors.
Rite Aid的破产计划旨在减轻20亿美元的债务，并向初级债权人分配4750万美元。
These creditors include individuals and local governments who have sued Rite Aid for allegedly ignoring red flags and illegally filling prescriptions for addictive opioid pain medication.
这些债权人包括声称Rite Aid忽视红旗，并非法填写成瘾性阿片类止痛药处方的个人和地方政府。
In October 2023, Walgreens Boots Alliance (NASDAQ:WBA) consented to a settlement of $192.5 million following allegations that some of the company's executives provided misleading information concerning its 2015 attempt to purchase Rite Aid.
2023年10月，沃尔格林-联合博姿（NASDAQ：WBA）同意支付1.925亿美元的和解金，以解决其部分高管在2015年试图收购Rite Aid时提供虚假信息的指控。
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
免责声明：本文部分内容使用了Benzinga Neuro的帮助。此内容是通过AI工具部分制作的，并由Benzinga编辑进行了审查和发布。
Photo via Wikimedia Commons
照片通过Wikimedia Commons